Plethico Pharmaceuticals

Plethico Pharma consolidated Jun '13 sales at Rs 518.21 crore

Plethico Pharmaceuticals has reported a sales turnover of Rs 518.21 crore and a net profit of Rs 44.40 crore for the quarter ended Jun '13

Plethico Pharma consolidated Mar '13 sales at Rs 490.50 crore

Plethico Pharmaceuticals has reported a sales turnover of Rs 490.50 crore and a net profit of Rs 13.23 crore for the quarter ended Mar '13

Plethico Pharmaceuticals touches 5% upper circuit

Plethico Pharmaceuticals is locked at 5 percent upper circuit on Tuesday after seeing a fall of 8.5 percent in previous two straight sessions.

Only buyers in Plethico Pharma, stock up 5%

In the Plethico Pharmaceuticals there were pending buy orders of 17,878 shares, with no sellers available. At 14:30 hrs the share was quoting at Rs 221.90, up Rs 10.55, or 4.99 percent.

Only buyers in Plethico Pharma, shares up 5% for 4th day

Plethico Pharmaceuticals is locked at 5 percent upper circuit for the fourth consecutive session on Monday.

Buy Plethico Pharma, JP Power, Shriram Transport: Tulsian

In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

Buy Plethico Pharma, Anant Raj; Sell Rel Comm: Tulsian

In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

Buy Plethico Pharma, Guj NRE, Suzlon Energy: SP Tulsian

In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

Plethico Pharma plunges for 5th consecutive session

Plethico Pharmaceuticals has been drifting lower and lower for the fifth consecutive session on Thursday. The stock has touched a new 52-week low and three-year low of Rs 193.05.

Plethico Pharma hits 3-year low, down 37% in 4 days

Plethico Pharmaceuticals has touched a three-year low of Rs 214.45 on Wednesday due to consistent selling pressure. The stock plunged 37.5% in four consecutive sessions.

Buy Dishman Pharma, Plethico Pharma:Rajesh Agarwal

In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.

Govt clears 25 FDI proposals worth Rs 2,973 crore

The government today said it has cleared 25 foreign direct investment (FDI) proposals, including that of AIF III of Mauritius and Mumbai based Microqual Techno, worth Rs 2,973.40 crore.

CRISIL assigns valuation grade of 5/5 to Plethico Pharma

CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has assigned a valuation grade of 5/5 to the company and assigned fundamental grade of 3/5 in its August 17, 2011 report.

CRISIL assigns valuation grade of 5/5 to Plethico Pharma

CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on the company with a Valuation Grade of ‘5/5’ and has maintained the fair value of Rs 530 per share.

CRISIL assigns valuation grade of 5/5 to Plethico Pharma

CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on Plethico Pharmaceuticals with a Valuation Grade of ‘5/5’ and has maintained the fair value of Rs 530 per share.

CRISIL assigns valuation grade of 5/5 to Plethico Pharma

CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on Plethico Pharmaceuticals with a Valuation Grade of ‘5/5’ and maintain the fair value of Rs 530 per share.

Expect around 18-20% growth going forward: Plethico Pharma

Sanjay Pai, CFO, Plethico Pharmaceuticals says, the company grew about 22% year-on-year. He further says, the company has been growing at a steady rate of 18-20%. He expects similar kind of growth going forward.